DENTSPLY SIRONA Inc. (NASDAQ:XRAY) was the target of a significant decrease in short interest in July. As of July 31st, there was short interest totalling 5,968,958 shares, a decrease of 18.2% from the July 14th total of 7,294,256 shares. Based on an average daily volume of 1,570,011 shares, the short-interest ratio is currently 3.8 days. Currently, 2.6% of the company’s stock are sold short.

A number of brokerages have recently issued reports on XRAY. Zacks Investment Research raised DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research report on Wednesday, April 19th. Credit Suisse Group reaffirmed an “outperform” rating and set a $75.00 price target (up from $67.00) on shares of DENTSPLY SIRONA in a research report on Thursday, July 13th. BidaskClub raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Friday, June 30th. TheStreet downgraded DENTSPLY SIRONA from a “b” rating to a “c+” rating in a research report on Wednesday. Finally, Morgan Stanley upped their price target on DENTSPLY SIRONA from $66.00 to $67.00 and gave the stock an “overweight” rating in a research report on Thursday. Two analysts have rated the stock with a sell rating, three have issued a hold rating and nine have assigned a buy rating to the company’s stock. DENTSPLY SIRONA presently has an average rating of “Buy” and an average price target of $66.75.

DENTSPLY SIRONA (NASDAQ:XRAY) opened at 55.33 on Friday. The firm’s market capitalization is $12.69 billion. DENTSPLY SIRONA has a 52-week low of $54.49 and a 52-week high of $65.68. The company has a 50 day moving average price of $62.91 and a 200 day moving average price of $62.30.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 EPS for the quarter, hitting the consensus estimate of $0.65. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. The firm had revenue of $992.70 million during the quarter, compared to analyst estimates of $1 billion. During the same quarter in the prior year, the business posted $0.76 earnings per share. DENTSPLY SIRONA’s revenue for the quarter was down 2.9% compared to the same quarter last year. On average, equities analysts forecast that DENTSPLY SIRONA will post $2.73 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, October 13th. Investors of record on Friday, September 29th will be given a dividend of $0.0875 per share. This represents a $0.35 annualized dividend and a yield of 0.63%. The ex-dividend date is Thursday, September 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -10.09%.

A number of institutional investors have recently modified their holdings of XRAY. Teachers Advisors LLC raised its position in shares of DENTSPLY SIRONA by 18.5% in the fourth quarter. Teachers Advisors LLC now owns 323,176 shares of the medical instruments supplier’s stock valued at $18,657,000 after buying an additional 50,432 shares during the period. Chevy Chase Trust Holdings Inc. raised its position in shares of DENTSPLY SIRONA by 1.5% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 202,398 shares of the medical instruments supplier’s stock valued at $12,638,000 after buying an additional 2,992 shares during the period. Raymond James Trust N.A. raised its position in shares of DENTSPLY SIRONA by 11.7% in the first quarter. Raymond James Trust N.A. now owns 6,031 shares of the medical instruments supplier’s stock valued at $377,000 after buying an additional 630 shares during the period. Creative Planning raised its position in shares of DENTSPLY SIRONA by 1.0% in the first quarter. Creative Planning now owns 6,800 shares of the medical instruments supplier’s stock valued at $425,000 after buying an additional 70 shares during the period. Finally, Gulf International Bank UK Ltd raised its position in shares of DENTSPLY SIRONA by 1.4% in the first quarter. Gulf International Bank UK Ltd now owns 74,565 shares of the medical instruments supplier’s stock valued at $4,655,000 after buying an additional 1,000 shares during the period. 95.17% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: “DENTSPLY SIRONA Inc. (XRAY) Short Interest Update” was first published by Watch List News and is the property of of Watch List News. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The correct version of this article can be accessed at https://www.watchlistnews.com/dentsply-sirona-inc-xray-short-interest-update/1476401.html.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.